↓ Skip to main content

Pitavastatin and Atorvastatin Double-Blind Randomized ComPArative Study among HiGh-Risk Patients, Including ThOse with Type 2 Diabetes Mellitus, in Taiwan (PAPAGO-T Study)

Overview of attention for article published in PLOS ONE, October 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
facebook
1 Facebook page
f1000
1 research highlight platform

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
98 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pitavastatin and Atorvastatin Double-Blind Randomized ComPArative Study among HiGh-Risk Patients, Including ThOse with Type 2 Diabetes Mellitus, in Taiwan (PAPAGO-T Study)
Published in
PLOS ONE, October 2013
DOI 10.1371/journal.pone.0076298
Pubmed ID
Authors

Ping-Yen Liu, Liang-Yu Lin, Hung-Ju Lin, Chien-Hsun Hsia, Yi-Ren Hung, Hung-I Yeh, Tao-Cheng Wu, Ju-Yi Chen, Kuo-Liong Chien, Jaw-Wen Chen

Abstract

Evidence about the efficacy and safety of statin treatment in high-risk patients with hypercholesterolemia is available for some populations, but not for ethnic Chinese. To test the hypothesis that treatment with pitavastatin (2 mg/day) is not inferior to treatment with atorvastatin (10 mg/day) for reducing low-density lipoprotein cholesterol (LDL-C), a 12-week multicenter collaborative randomized parallel-group comparative study of high-risk ethnic Chinese patients with hypercholesterolemia was conducted in Taiwan. In addition, the effects on other lipid parameters, inflammatory markers, insulin-resistance-associated biomarkers and safety were evaluated.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 1 1%
Netherlands 1 1%
Denmark 1 1%
Unknown 95 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 16%
Student > Bachelor 13 13%
Student > Ph. D. Student 10 10%
Researcher 7 7%
Other 7 7%
Other 12 12%
Unknown 33 34%
Readers by discipline Count As %
Medicine and Dentistry 33 34%
Biochemistry, Genetics and Molecular Biology 7 7%
Nursing and Health Professions 7 7%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Agricultural and Biological Sciences 3 3%
Other 8 8%
Unknown 35 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2016.
All research outputs
#13,897,567
of 22,723,682 outputs
Outputs from PLOS ONE
#112,115
of 193,985 outputs
Outputs of similar age
#113,747
of 207,105 outputs
Outputs of similar age from PLOS ONE
#2,789
of 5,023 outputs
Altmetric has tracked 22,723,682 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 193,985 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.1. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,105 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5,023 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.